Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats

Alexandre Seillier, Andrea Giuffrida

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Sub-chronic administration of PCP produces a social interaction deficit that is reversed by URB597, an inhibitor of the catabolic enzyme of the endocannabinoid anandamide. Since increased anxiety may contribute to social withdrawal and URB597 has been shown to have an anxiolytic action, we studied whether this drug affected saline- and PCP-treated rats' performance in the Elevated-Plus-Maze task, which has been used to assess anxiety-like effects. Sub-chronic PCP produced a CB1-dependent decrease in anxiety-like behavior that was reversed by URB597 in a CB1-independent fashion, as it was not blocked by the CB1 antagonist AM251. These findings suggest that PCP-treated rats have altered endocannabinoid transmission and that anxiety does not contribute to the PCP-induced social withdrawal.

Original languageEnglish (US)
Pages (from-to)583-586
Number of pages4
JournalPharmacology Biochemistry and Behavior
Issue number4
StatePublished - Jun 2011


  • AM251
  • Anandamide
  • Cannabinoid CB receptor
  • Elevated Plus Maze
  • Phencyclidine
  • URB597

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience


Dive into the research topics of 'Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats'. Together they form a unique fingerprint.

Cite this